Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diethyl [(1R)-1,5-diaminopentyl]boronate is an experimental drug candidate belonging to the class of boronic acid derivatives. Boronic acids are a group of boron-containing compounds that have gained increasing interest in medicinal chemistry due to their diverse biological activities, including anticancer, antibacterial, and antiviral properties. While the specific mechanism of action for this particular compound is not detailed in available information, boronic acid derivatives are known to act as enzyme inhibitors, with some, like bortezomib, functioning as proteasome inhibitors, and others as beta-lactamase inhibitors. It is currently in an experimental stage of development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diethyl [(1R)-1,5-diaminopentyl]boronate.